ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action – AQST

PR Newswire

NEW YORK, April 1, 2021 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between December 2, 2019 and September 25, 2020, inclusive (the “Class Period”), of the important April 30, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Aquestive securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Aquestive class action, go to http://www.rosenlegal.com/cases-register-2047.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 30, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE:  According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) data included in the Libervant Buccal Film for the management of seizure clusters (“Libervant”) New Drug Application (“NDA”) submission showed a lower drug exposure level than desired for certain weight groups; (2) the foregoing significantly decreased the Libervant NDA’s approval prospects; (3) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the Libervant NDA in its current form; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Aquestive class action, go to http://www.rosenlegal.com/cases-register-2047.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

Cision View original content:http://www.prnewswire.com/news-releases/rosen-top-ranked-investor-counsel-encourages-aquestive-therapeutics-inc-investors-to-secure-counsel-before-important-april-30-deadline-in-securities-class-action–aqst-301261107.html

SOURCE Rosen Law Firm, P.A.

BetterInvesting™ Magazine Chooses O’Reilly Automotive Inc. As “Growth” Stock and Masco Corp. As “Undervalued” For June 2021

PR Newswire

TROY, Mich., April 1, 2021 /PRNewswire/ — The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced O’Reilly Automotive Inc. (NASDAQ:ORLY) as its “Stock to Study” and Masco Corp. (NYSE:MAS) is its “Undervalued Stock” in the June/July 2021 issue for investors’ informational and educational use.

“As stimulus checks arrive across the country this week, Americans may be asking if they should invest some of their windfall. Take the time to learn how to invest wisely before jumping in.  Helpful tips at: https://www.betterinvesting.org/learn-about-investing/investor-education/investing/how-to-invest-your-stimulus-check,” said Ken Zendel, the chief executive officer of the National Association of Investors Corp. (NAIC), the parent organization of BetterInvesting.

Check BetterInvesting’s June/July 2021 issue for more details about latest stock selections. Go to the trial version of BetterInvesting’s online tools to study the investment potential of O’Reilly and Masco by viewing their fundamental data and applying judgments.

Committee members are Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; and Walter J. Kirchberger, CFA.

As stated, the BetterInvesting committee’s Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.

About BetterInvesting:

BetterInvesting, a national 
501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors Corporation (NAIC), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting is dedicated to providing unbiased, in-depth investing education and powerful online stock analysis tools in order to create successful lifelong investors. BetterInvesting staff along with a dedicated community of volunteers across America teach the organization’s principles and time-tested methodology to both individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org.

Follow us on LinkedIn and Facebook.

Media Contact:
BetterInvesting
1-877-275-6242

Cision View original content:http://www.prnewswire.com/news-releases/betterinvesting-magazine-chooses-oreilly-automotive-inc-as-growth-stock-and-masco-corp-as-undervalued-for-june-2021-301261109.html

SOURCE NAIC-BetterInvesting

ROSEN, A TOP RANKED LAW FIRM, Encourages Volkswagen AG Investors to Inquire About Class Action Investigation – VWAGY, VWAPY, VLKAF, VLKPF

ROSEN, A TOP RANKED LAW FIRM, Encourages Volkswagen AG Investors to Inquire About Class Action Investigation – VWAGY, VWAPY, VLKAF, VLKPF

NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Volkswagen AG (OTC: VWAGY, VWAPY, VLKAF, VLKPF) resulting from allegations that Volkswagen AG may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Volkswagen AG securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to http://www.rosenlegal.com/cases-register-2072.htmlor call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

WHAT IS THIS ABOUT: On March 29, 2021, CNBC published an article entitled “VW accidentally leaks new name for its U.S. operations: Voltswagen” stating that “Volkswagen is expected to change the name of its operations in the U.S. to ‘Voltswagen of America,’ emphasizing the German automaker’s electric vehicle efforts” and that “[a] now unpublished press release called the change a ‘public declaration of the company’s future-forward investment in e-mobility.’”

Then on March 30, 2021, the Wall Street Journal published an article entitled “No, Volkswagen Isn’t Rebranding Itself Voltswagen” which stated “[t]he name change stunt comes as the company is eager to get U.S. consumers jazzed about the ID. 4, which went on sale in U.S. showrooms this month.” The article also stated that “problem for VW is that everyone took it seriously, creating confusion about the company’s intentions and moving the shares[.]” Due to the earlier news, the article stated “[i]n the U.S., the company’s American depositary receipts rose as much as 12% Tuesday before sliding near the close after the company confirmed the name change was a joke, closing up 9%.”

On this news, Volkswagen’s American depositary receipt (“ADR”) price fell $2.17 per ADR, or 5%, over the next two trading days to close at $35.58 per ADR on April 1, 2021, damaging investors.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

CIB Marine Bancshares, Inc. Issues Counterproposal to Hildene Plan

BROOKFIELD, Wis., April 01, 2021 (GLOBE NEWSWIRE) — CIB Marine Bancshares, Inc. (the “Company” or “CIB Marine”) (OTCQB: CIBH), has issued a letter to its shareholders in response to a proxy statement issued by offshore hedge fund, Hildene Opportunities Master Fund, Ltd. (“Hildene”). CIB Marine’s letter highlights financial performance measures over the last five years, answers shareholder questions related to Hildene’s recent communications and, most importantly, proposes a fair plan that is accretive to value as an alternative to Hildene’s self-enriching repurchase plan. The Company’s proposed preferred stock repurchase plan includes the repurchase of 50% of the Company’s currently outstanding preferred stock in 2021 with intentions to pursue future repurchases with a goal of retiring all preferred stock within four years of the first repurchase, subject to financial and other considerations. Highlights are included here with additional detail in the letter, which is available along with other Annual Meeting materials on CIB Marine’s website: www.cibmarine.com/2021AnnualMeeting.asp.

  CIB Marine Plan Hildene Plan
Shares to be Repurchased in 2021 21,946 pro-rata (50.0%) 23,529 (53.6%)
Price Per Share $775 $850
SubDebt Required None $20 million
Mandatory Payment of 7% Dividends No (no change to current
noncumulative terms)
Yes (changes current
noncumulative terms)
Repurchase Order Pro-rata Series A and
Series B
Mandatory purchase of
Series A before Series B
Accretive to Common Tangible Book
Value
Yes No
Article Amendment Required Yes Yes

J. Brian Chaffin, CIB Marine’s President and CEO said, “Our estimates indicate that Hildene’s proposed plan would take twice as long as our plan to repurchase all outstanding preferred shares and it would require us to pay more than $20 million combined in debt service and preferred dividends, not including the repayment of subordinated debt or the price paid for the repurchased shares. We believe that using our currently available cash for repurchases is far more productive for all parties and would create immediate value for our common shareholders at a price above prior Preferred Stock repurchases.”

Mr. Chaffin concluded, “Our shareholders will receive a copy of our letter with a WHITE proxy card in an upcoming mailing from CIB Marine. While shareholders may be tempted to express displeasure with Hildene’s proposal, the strongest message our shareholders could send to Hildene is to discard any materials received from Hildene and overwhelmingly vote our WHITE Proxy Card in support of our Board nominees, who have guided us in our disciplined repurchase efforts.”   

CIB Marine Bancshares, Inc. is the holding company for CIBM Bank, which operates ten banking offices and five mortgage loan offices in Illinois, Wisconsin and Indiana. More information on the Company is available at www.cibmarine.com, including recent shareholder letters, links to regulatory financial reports, and audited financial statements.


FORWARD-LOOKING STATEMENTS


CIB Marine has made statements in this release that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. CIB Marine intends these forward-looking statements to be subject to the safe harbor created thereby and is including this statement to avail itself of the safe harbor. Forward-looking statements are identified generally by statements containing words and phrases such as “may,” “project,” “are confident,” “should be,” “intend,” “predict,” “believe,” “plan,” “expect,” “estimate,” “anticipate” and similar expressions. These forward-looking statements reflect CIB Marine’s current views with respect to future events and financial performance that are subject to many uncertainties and factors relating to CIB Marine’s operations and the business environment, which could change at any time.

There are inherent difficulties in predicting factors that may affect the accuracy of forward-looking statements.

Stockholders should note that many factors, some of which are discussed elsewhere in this Earnings Release and in the documents that are incorporated by reference, could affect the future financial results of CIB Marine and could cause those results to differ materially from those expressed in forward-looking statements contained or incorporated by reference in this document. These factors, many of which are beyond CIB Marine’s control, include but are not limited to:

  • operating, legal, execution, credit, market, security (including cyber), and regulatory risks;
  • economic, political, and competitive forces affecting CIB Marine’s banking business;
  • the impact on net interest income and securities values from changes in monetary policy and general economic and political conditions; and
  • the risk that CIB Marine’s analyses of these risks and forces could be incorrect and/or that the strategies developed to address them could be unsuccessful.

These factors should be considered in evaluating the forward-looking statements, and undue reliance should not be placed on such statements. Forward-looking statements speak only as of the date they are made. CIB Marine undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Forward-looking statements are subject to significant risks and uncertainties and CIB Marine’s actual results may differ materially from the results discussed in forward-looking statements.

FOR INFORMATION CONTACT:
J. Brian Chaffin, President & CEO
(217) 355-0900
[email protected]



Overseas Shipholding Group to Announce Fourth Quarter and Full Year 2020 Results on April 7, 2021

Overseas Shipholding Group to Announce Fourth Quarter and Full Year 2020 Results on April 7, 2021

TAMPA, Fla.–(BUSINESS WIRE)–
Overseas Shipholding Group, Inc. (NYSE: OSG) (the “Company” or “OSG”) announces that it has filed its Annual Report on Form 10-K today and that it will host a conference call to discuss its fourth quarter and full year 2020 results at 9:30 a.m. Eastern Time (“ET”) on Wednesday, April 7, 2021.

To access the call, participants should dial (844) 850-0546 for domestic callers and (412) 317-5203 for international callers. Please dial in ten minutes prior to the start of the call.

A live webcast of the conference call will be available from the Investor Relations section of the Company’s website at http://www.osg.com.

An audio replay of the conference call will be available starting at 11:30 a.m. ET on Wednesday, April 7, 2021 by dialing (877) 344-7529 for domestic callers and (412) 317-0088 for international callers and entering Access Code 10153746.

About Overseas Shipholding Group, Inc

Overseas Shipholding Group, Inc. (NYSE: OSG) is a publicly traded company providing energy transportation services for crude oil and petroleum products in the U.S. Flag markets. OSG is a major operator of tankers and ATBs in the Jones Act industry. OSG’s 22 vessel U.S. Flag fleet consists of three crude oil tankers doing business in Alaska, two conventional ATBs, two lightering ATBs, three shuttle tankers, ten MR tankers, and two non-Jones Act MR tankers that participate in the U.S. Maritime Security Program. OSG also currently owns and operates two Marshall Islands flagged MR tankers which trade internationally.

OSG is committed to setting high standards of excellence for its quality, safety and environmental programs. OSG is recognized as one of the world’s most customer-focused marine transportation companies and is headquartered in Tampa, FL. More information is available at www.osg.com.

Investor Relations & Media Contact:

Susan Allan, Overseas Shipholding Group, Inc.

(813) 209-0620

[email protected]

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS: Maritime Transport Oil/Gas Manufacturing Energy Other Manufacturing

MEDIA:

Logo
Logo

KKR & Urban Renaissance Group Acquire 300 Pine Building in Downtown Seattle

KKR & Urban Renaissance Group Acquire 300 Pine Building in Downtown Seattle

Iconic 770,000 SF, Eight-Story Historic Mixed-Use Building to Feature Class A Office Space and Renovated Ground-Level Retail

SEATTLE–(BUSINESS WIRE)–
Seattle-based commercial real estate firm Urban Renaissance Group LLC (www.urbanrengroup.com) (URG) and KKR, a leading global investment firm, today announced the acquisition of the 300 Pine St building in downtown Seattle.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210401005945/en/

Seattle-based commercial real estate firm Urban Renaissance Group LLC (URG) and KKR, a leading global investment firm, today announced the acquisition of the 300 Pine St building in downtown Seattle. Located on a full city block between 3rd Ave and 4th Ave in the heart of Seattle’s retail core, the 770,000 sq. ft., eight-story mixed-use iconic building with its historic façade will feature 85,000 sq. ft. renovated ground-floor retail designed to accommodate retail flagship stores, along with a new stunning 4th Avenue entrance to access the 682,000 sq. ft. of commercial office space currently fully-leased to a single tenant. The office portion will feature 80,000 sq. ft. floorplates, seismic retrofitting, and over twenty skylights including two light wells providing additional light for the top two floors. (Photo: Business Wire)

Seattle-based commercial real estate firm Urban Renaissance Group LLC (URG) and KKR, a leading global investment firm, today announced the acquisition of the 300 Pine St building in downtown Seattle. Located on a full city block between 3rd Ave and 4th Ave in the heart of Seattle’s retail core, the 770,000 sq. ft., eight-story mixed-use iconic building with its historic façade will feature 85,000 sq. ft. renovated ground-floor retail designed to accommodate retail flagship stores, along with a new stunning 4th Avenue entrance to access the 682,000 sq. ft. of commercial office space currently fully-leased to a single tenant. The office portion will feature 80,000 sq. ft. floorplates, seismic retrofitting, and over twenty skylights including two light wells providing additional light for the top two floors. (Photo: Business Wire)

Located on a full city block between 3rd Ave and 4th Ave in the heart of Seattle’s retail core, the 770,000 sq. ft., eight-story mixed-use iconic building with its historic façade will feature 85,000 sq. ft. renovated ground-floor retail designed to accommodate retail flagship stores, along with a new stunning 4th Avenue entrance to access the 682,000 sq. ft. of commercial office space currently fully-leased to a single tenant. The office portion will feature 80,000 sq. ft. floorplates, seismic retrofitting, and over twenty skylights including two light wells providing additional light for the top two floors.

Originally home to Seattle’s beloved Bon Marché department store, the art-deco style building was constructed in 1929 with four additional stories added in 1955. Between 2015 and 2017, then-owner Macy’s sold the upper six levels for office space, and in 2020 the department store closed. The renovated landmark building will feature a timeless façade, a 20,000 sq. ft. rooftop deck, one-of-a-kind interiors, and 15-foot tall ceilings with ornate colonnades and dramatic architectural features that originate from the 1920’s era department stores. The historic building elements will be reinvigorated with a contemporary plan that connects multiple program elements though a central common area.

The new ground-level retail space, conveniently located above the underground Westlake Light Rail Station with bus stops at the west (3rd Ave) and east (4th Ave) entrances, will be named ‘The Bon Marché Collective’ in honor of the building’s history. It will offer retail suites for lease ranging from approximately 3,000 sq. ft. to 16,600 sq. ft. with additional potential for a ground-floor grand food hall. Victrola Coffee currently occupies retail space on 3rd Ave and will remain at the building’s southwest corner.

“Investing in this historic building marks our fourth investment in the Puget Sound Region,” said Justin Pattner, KKR’s Head of Real Estate Equity in the Americas. “This is an attractive market poised for long-term growth driven by its strong and growing workforce, attractive cost of living, and simply being a highly desirable place to live with a great quality of life. 300 Pine is an important part of Seattle’s community and we are looking forward to bringing it to its full potential.”

Billy Butcher, Chief Operating Officer of KKR’s Global Real Estate business, added: “We believe in the strong potential of unique and iconic buildings that serve large corporate users with long-term leases and we are very excited to invest in 300 Pine as part of our Prime Single Tenant strategy. We have acquired over ten million square feet of similarly situated buildings recently and the Puget Sound Region has quickly become a large part of that strategy, given our belief in the region’s attractive fundamentals.”

“Originally constructed as a monument to Seattle’s retail strength in the Pacific Northwest, this beautiful historic building remains a symbol of our city’s strength and resilience,” said Urban Renaissance Group CEO Patrick Callahan. “We’re thrilled about this transaction with KKR and excited about the future of this building. This acquisition reflects our mutual confidence in the region and specifically in downtown Seattle, where we look forward to strengthening the heart of Seattle’s retail core.”

KKR’s Confidence in the Puget Sound Region

300 Pine marks KKR’s fourth acquisition in the Puget Sound region. Since entering the Seattle real estate market less than a year-and-a-half ago, KKR has completed several major transactions with URG totaling more than two million sq. ft.:

  • The Summit, a three building, 915,000 sq. ft. Class A office complex in Bellevue’s central business district.
  • Tower 333, a 20-story, Class A office tower in Bellevue’s central business district which is fully leased to a single tenant.
  • F5 Tower, a 43-story, Class A office tower in downtown Seattle which is fully leased.

KKR is making the investment from one of its sponsored real estate investment vehicles focused on high-quality, stabilized, income-oriented assets.

For current retail leasing inquiries within the Bon Marché Collective at 300 Pine, interested parties can contact Maria Royer at Real Retail ([email protected]).

Eastdil Secured represented the Seller in the transaction and advised KKR and URG on the financing.

About Urban Renaissance Group

Urban Renaissance Group LLC is a Seattle-based full-service commercial real estate company, engaged in acquisitions, development, asset management, leasing, property management and ownership in Seattle, Bellevue, Denver and Portland. Founded in 2006, the strategic premise of Urban Renaissance Group (URG) is that the form of the American City is changing. URG acts as a catalyst that understands and ignites that change, thereby building community, generating appropriate returns for its investors and opportunities for its partners and employees. Learn more at www.urbanrengroup.com.

About KKR

KKR is a leading global investment firm that offers alternative asset management and capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of The Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co

URG

Natalie Quick

206-779-0489

[email protected]

KKR

Miles Radcliffe-Trenner

212-750-8300

[email protected]

KEYWORDS: United States North America Washington

INDUSTRY KEYWORDS: Professional Services Architecture Commercial Building & Real Estate Finance Construction & Property REIT

MEDIA:

Photo
Photo
Seattle-based commercial real estate firm Urban Renaissance Group LLC (URG) and KKR, a leading global investment firm, today announced the acquisition of the 300 Pine St building in downtown Seattle. Located on a full city block between 3rd Ave and 4th Ave in the heart of Seattle’s retail core, the 770,000 sq. ft., eight-story mixed-use iconic building with its historic façade will feature 85,000 sq. ft. renovated ground-floor retail designed to accommodate retail flagship stores, along with a new stunning 4th Avenue entrance to access the 682,000 sq. ft. of commercial office space currently fully-leased to a single tenant. The office portion will feature 80,000 sq. ft. floorplates, seismic retrofitting, and over twenty skylights including two light wells providing additional light for the top two floors. (Photo: Business Wire)

Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2021

Monthly information regarding the total number of voting rights and

total number of shares of the Company as of March 31, 2021

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345

 

Date

 

Total number of shares Total number of voting rights
03/31/2021 54,936,687  

Total gross of voting rights: 54,936,687

 

 

Total net* of voting rights:  54,876,099

 

* Total net = total number of voting rights attached to shares – shares without voting rights

Attachment



Enterprise Financial Services Corp Announces First Quarter 2021 Earnings Release and Conference Call

Enterprise Financial Services Corp Announces First Quarter 2021 Earnings Release and Conference Call

ST. LOUIS–(BUSINESS WIRE)–
Enterprise Financial Services Corp (Nasdaq: EFSC) (“the Company” or “EFSC”) will release its first quarter 2021 financial results on Monday, April 26, 2021. The Company will host a conference call and webcast at 10:00 a.m. CT on Tuesday, April 27, 2021. The conference call will be accessible by telephone at 1-800-353-6461 (Conference ID #2910583). The webcast will be accessible via the “Investor Relations” page of the Company’s website, www.enterprisebank.com. The press release and related presentation slides will be accessible via the same website page prior to the scheduled call. A recorded replay of the conference call will be available on the website beginning two hours after the call’s completion. To access the audio replay, please visit http://bit.ly/EFSC1Q2021earnings. The replay will be available for approximately two weeks following the conference call.

Enterprise Financial Services Corp (Nasdaq: EFSC), with approximately $9.8 billion in assets, is a financial holding company headquartered in Clayton, Missouri. Enterprise Bank & Trust, a Missouri state-chartered trust company with banking powers and a wholly-owned subsidiary of EFSC, operates 39 branch offices in Arizona, California, Kansas, Missouri, Nevada, and New Mexico, and SBA loan and deposit production offices in Arizona, California, Colorado, Illinois, Indiana, Massachusetts, Michigan, Nevada, Ohio, Oregon, Texas, Utah, and Washington. Enterprise Bank & Trust offers a range of business and personal banking services, and wealth management services. Enterprise Trust, a division of Enterprise Bank & Trust, provides financial planning, estate planning, investment management, and trust services to businesses, individuals, institutions, retirement plans and non-profit organizations. Additional information is available at www.enterprisebank.com.

Enterprise Financial Services Corp’s common stock is traded on the Nasdaq Stock Market under the symbol “EFSC.” Please visit our website at www.enterprisebank.com to see our regularly posted material information.

For Investor Relations Contact:

Keene Turner, Executive Vice President and CFO (314) 512-7233

For Media Inquiries Contact:

Steve Richardson, Vice President, Corporate Communication (314) 512-7183

KEYWORDS: United States North America Missouri

INDUSTRY KEYWORDS: Banking Other Professional Services Professional Services Finance

MEDIA:

Logo
Logo

Heritage Cannabis Reports First Quarter 2021 Financial Results

Heritage Cannabis Reports First Quarter 2021 Financial Results

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritageor the “Company”), today announced its financial results as at and for the three months ended January 31, 2021 (“Q1 2021”). All figures are in Canadian dollars unless otherwise noted.

“As we have stated previously, first quarter results do not include the positive impacts of the Premium 5 acquisition given the transaction closed at the end of the quarter, nor does it include results from our initial medical launch which will begin later this month,” stated Clint Sharples, Chief Executive Officer of Heritage. “As we move forward, we expect to see continued acceleration in both our medical and recreational product divisions with the addition of Premium 5 starting to have a material effect in Canada. Additionally, with our imminent launch in the multi-billion dollar U.S. market, and continued growth from our Pura Vida and Purefarma brands we expect to be well positioned to drive further positive results and shareholder value.”

Selected financial highlights for the three-month periods ended January 31, 2021, January 31, 2020, and October 31, 2020 include the following:

(in $CDN)

 

Three months ended January 31, 2021

 

Three months ended January 31, 2020

 

Three months ended October 31, 2020

 

 

 

 

 

 

 

Gross Revenue

$

1,827,273

$

4,008,395

$

1,500,750

Net Revenue

$

1,520,616

$

3,631,582

$

1,429,973

 

 

 

 

 

 

 

Cost of Sales

$

1,010,361

$

2,248,806

$

298,214

Gross Margin

$

510,255

$

1,382,776

$

1,131,759

 

 

 

 

 

 

 

General and Administrative Expenses1

$

4,179,758

$

2,902,6121

$

510,188

Other Income (Expenses)

 

$

38,750

$

(424,983)

$

(5,017,017)

Comprehensive Income (Loss)

$

(3,211,082)

$

(2,018,266)

$

(4,745,405)

1 Restated to agree with current period presentation.

Q1 2021 Financial Highlights

  • The Company reported gross revenue of $1,827,273 for the three-month period ended January 31, 2021, a decrease of $2,181,122 compared to the same three-month period in fiscal 2020. The decline in gross revenue was the result of the transition from primarily third-party contracts to branded sales to the provincial boards. The Company began selling its branded products to the provincial boards part way through the fourth quarter of 2020.
  • Cost of sales for the three-month period ended January 31, 2021 was $1,010,361 resulting in a gross margin on sales of $510,255 compared to gross margin of $1,382,776 for the three-month period ended January 31, 2020. The decline in gross margin was the result of the above mentioned continuing transition from primarily third-party contracts to branded sales to the provincial boards.
  • For the three-month period ended January 31, 2021, the Company recorded a comprehensive loss of $3,211,082 or $0.01 loss per share compared to a comprehensive loss of $2,018,266 or $0.01 loss per share for the three-month period ended January 31, 2020.

Q1 2021 Growth, Operational, and Corporate Highlights

  • On November 2, 2020, the Company announced it received its first order for products from Weed Pool Cannabis Co-operative (“Weed Pool”) in the Province of Saskatchewan. Weed Pool is a co-operative of independently-owned Saskatchewan cannabis retailers representing more than 50% of licensed cannabis sales in the province. It is a cannabis wholesaler licensed by the Saskatchewan Liquor and Gaming Authority (“SLGA”) focused on collectively sourcing cannabis products for its members and other retailers in Saskatchewan. With over 60% of licensed cannabis retailers in Saskatchewan comprised of independent stores, Weed Pool offers all Heritage products efficient access across their retail distribution network, and provides retailers with products and pricing for which they may not otherwise have access.
  • On November 18, 2020, the Company announced that it signed an agreement with Alberta Gaming, Liquor & Cannabis (“AGLC”) to sell Heritage products in Alberta, and on December 14, 2020 received the first order from the province. Products ordered include all seven vape cartridge products offered by Heritage including Pura Vida CBD 4:1 Honey Oil, and Indica, Sativa and Hybrid Honey Oil vape cartridges, as well as Purefarma Moon, Sun and CBD Earth vape cartridges.
  • On December 11, 2020, the Company announced that it accepted the resignation of its auditor MNP LLP (“Former Auditor”) as of December 8, 2020 and that the board of directors of the Company appointed Davidson & Company LLP (“Successor Auditor”) as the Company’s auditor effective December 8, 2020. There were no reservations or modified opinions in the Former Auditor’s audit reports for the Company. There are no “reportable events” (as the term is defined in National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”)) between the Company and the Former Auditor. In accordance with NI 51-102, the notice of change of auditor, together with the required letters from the Former Auditor and the Successor Auditor, were reviewed by the board of directors of the Company and filed on SEDAR.
  • On December 15, 2020, the Company announced that it entered into an arrangement with CannaBR Exports Corp (“CannaBR”), a Brazilian focused pharmaceutical CBD product importation and distribution company, for the distribution and sale of bulk CBD products to the Brazilian cannabis market. Heritage, in conjunction with CannaBR, is focused on filing and achieving approvals from the Brazil Health Authority (ANVISA) to distribute and sell bulk CBD products in Brazil and is currently in advanced stages of product stability testing to meet ANVISA’s requirements. Further, through the arrangement, Heritage established contracts with minimum order quantities agreed to by both parties to deliver CBD products in bulk to CannaBR’s large distribution network in Brazil with the option to establish long-term distribution contracts. Upon satisfying product stability testing requirements under ANVISA, in addition to the minimum order contracts currently in place with CannaBR, the Company will commence final negotiations to secure a long-term sales agreement for a 5 year term with a 5 year extension.
  • On December 23, 2020, Heritage announced that it entered into a definitive agreement (the “Agreement”) to acquire all of the issued and outstanding securities of Premium 5 Ltd. (“Premium 5”), a Canada-based recreational and medical cannabis company that creates high-quality full spectrum concentrates under the brand Premium 5. Premium 5 is a leader in developing and launching products, proven by successfully introducing one of the first hydrocarbon products in the Canadian recreational and medical markets as well as becoming the first to launch live resin vapes. Premium 5 offers a wide range of high-quality products that encompass premium, core, and value priced brands in both the recreational and medical markets, creating a leading portfolio of products in the Cannabis 2.0 space focused on derivative concentrates. It is best known for its namesake brand – Premium 5 in the premium hydrocarbon and solventless concentrates category, as well as the newly launched RAD value brand in the value hydrocarbon concentrate, flower and distillate vape categories. Premium 5 has entered nine of the 13 provincial and territorial recreational markets including the three largest, Ontario, Alberta and British Columbia and have strong product listings on the two leading medical platforms; Shelter Market and Shoppers Drug Mart’s online cannabis platform. Premium 5 has a strong product development pipeline with a focus on innovation and quality. With the acquisition, Heritage realizes immediate coast to coast sales, strong margins with an opportunity to drive additional synergies, an increased focus on execution and speed-to-market, and a strong product development pipeline. The acquisition was completed on January 26, 2021, and as consideration for the acquisition, the Company issued 150,000,000 Heritage common shares. The Company will issue additional Heritage common shares upon achieving a series of revenue milestones and maintaining minimum gross margin objectives over 24 months. The Company is currently assessing its accounting treatment of the acquisition, including the evaluation and fair value measurement of consideration paid, assets acquired, and liabilities assumed.
  • On January 7, 2021, the Company announced that it executed a definitive supply agreement with IntelGenx Corp. (“IntelGenx”) for the manufacturing and supply of filmstrip products containing 10 mg of CBD using IntelGenx’s VersaFilm® technology (“CBD Filmstrips”) for the Canadian and Australian markets. Under the Agreement, Heritage placed its first purchase order for 50,000 CBD Filmstrips that will be sold in select provincial retailers and the direct-to-consumer medical channel in Canada. The CBD Filmstrips will be formulated with both CBD and CBDA as CBDA has shown more potent activity at 5-HT1A (serotonin) receptors in published studies. The CBD Filmstrips, which dissolve orally, are meant to enable better and faster absorption than oral tinctures and capsules. IntelGenx expects to make its first shipment of product to Heritage in the second quarter of 2021. Pursuant to the Agreement, Heritage is supplying CBD material for IntelGenx’s filmstrip manufacture and supply in Canada and Australia on a non- and semi-exclusive basis, respectively. The CBD Filmstrips are being produced at IntelGenx’s manufacturing facility under Canadian GPP conditions and are registered as a product for sale with Health Canada as a cannabis product governed by the Cannabis Act and with the Australian Department of Health’s Therapeutic Goods Administration as a medicinal cannabis product governed by the Narcotic Drugs Act.
  • On January 11, 2021, the Company announced the launch of Premium 5 brand RAD, a new value brand dedicated to providing cannabis concentrate/extract consumers with affordable products while still maintaining the highest quality standard possible. The variety of different product formats seek to appeal to the unique needs and preferences of all types of cannabis consumers. High prices have been a regular consumer complaint after Canada legalized recreational cannabis in 2018. Although the legal market has continued to grow, the legacy market still owns a significant percentage of cannabis sales in the country. For consumers, there is an uncertainty surrounding the ingredients and additives in products that are purchased from the legacy market that could potentially be harmful. RAD is committed to attracting consumers to the benefits of regulated and tested products through legacy-competitive pricing and in the interest of public health and safety.
  • On January 19, 2021, the Company announced that its subsidiary CannaCure entered into a binding letter of intent with Entourage Participações S.A. (“Entourage Phytolab”) for a three-year extraction and finished product supply agreement for the distribution of pharmaceutical products in Brazil. Under the terms of the Agreement, Heritage will supply to Entourage Phytolab, hemp-derived CBD dominant extract, cannabis-derived THC dominant extract, and hemp-derived CBD 25 mg softgels and cannabis-derived THC dominant 2.5 and 5.0 mg softgels. As part of the long-term agreement, CannaCure will be providing cannabis and hemp products to be used strictly for pharmaceutical products that comply with regulations issued by the Brazil Health Authority (Anvisa), which include GMP certification and GMP compliant products. CannaCure is currently in the process of obtaining GMP certification. CannaCure will supply initial products for Entourage Phytolab’s formulation and research and development purposes, with commercial orders delivered following CannaCure receiving EU GMP certification estimated in the latter half of 2021. CannaCure and Entourage Phytolab have established minimum order quantities mutually agreed to by both parties.
  • On January 29, 2021, the Company announced that it received the first order from the Ontario Cannabis Store (“OCS”) to sell its Purefarma and Pura Vida branded products in the province. With these orders, Heritage now has three brands available in Ontario, as the newly acquired Premium 5 brand has been available at the OCS since early December 2020. The OCS is carrying Pura Vida’s DayBreak Sativa Honey Oil Drops and NightFall Indica Honey Oil Drops, as well as Purefarma’s Hemplixir 30 CBD Oil and 15:15 Balance CBD Oil. These brands are also available for purchase in British Columbia, Alberta, Saskatchewan, and Manitoba, as well as across Canada via medical access at www.patient-choice.com.

Financial Statements

The consolidated financial statements of the Company as at and for the three month period ended January 31, 2021 and accompanying management’s discussion and analysis have been filed with the securities regulators and are available on SEDAR at www.sedar.com under the Company’s issuer profile.

About Heritage Cannabis Holdings Corp.

Heritage is a cannabinoid company focused on the production and sale of medical and recreational hemp-based and cannabis-based products and services. In Canada, Heritage operates through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp., both regulated under the Cannabis Act Regulations. Working under these subsidiaries and the Purefarma, Pura Vida, Premium 5, RAD and feelgood. brands, Heritage focuses on extraction and the creation of derivative products for recreational consumers, as well as the formulation of cannabis based medical solutions. In the U.S., Heritage operates under Opticann Inc., a Colorado based oral and topical cannabinoid company with the rights to exclusively sell CBD and CBG products made with the patented VESIsorb® drug delivery system for optimized absorption and stability. As the parent company, Heritage is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

“Clint Sharples”

Clint Sharples

CEO

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information contained herein may include, but is not limited to, assumptions related to cash flow and capital resources, and expectations related to the supply and manufacturing agreements, the intended expansion of the Company, and partnerships and Joint Venture Partnerships.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements.

An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading “Risks and Uncertainties” in the Company’s annual management discussion and analysis for the year ended October 31, 2020 and dated February 26, 2021. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.

In connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by this notice.

Clint Sharples

Tel: 416-705-8529

[email protected]

or

Kelly Castledine

Tel: 647-660-2560

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Alternative Medicine Retail Health Manufacturing Specialty Other Manufacturing

MEDIA:

Logo
Logo

Regional Health Properties Reports Fourth Quarter and Full-Year 2020 Financial Results

Regional Health Properties Reports Fourth Quarter and Full-Year 2020 Financial Results

ATLANTA–(BUSINESS WIRE)–Regional Health Properties, Inc. (NYSE American: RHE) (NYSE American: RHEpA), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care, reported results for the year ended December 31, 2020.

Business Update

  • Successfully transitioned two non-performing facilities affiliated with one operator, preliminary results for transitioned facilities for January and February 2021 very encouraging
  • Collected 91% of 2020 cash rent
  • Generated positive free cash flow from continuing operations for the fourth quarter and year ended December 31, 2020, despite covid-19 headwinds

Brent Morrison, Regional Health Properties’ Chief Executive Officer and President, commented, “Our portfolio occupancy experienced some softness going into yearend but we remain hopeful that the vaccine rollout and reinstating family visitation privileges should reverse the downward trend by the second half of 2021. We have a strong and experienced portfolio of operating partners and remain confident in their abilities to continue to navigate through the challenges resulting from the ongoing pandemic.” Ben Waites, Regional’s Chief Financial Officer added “I’m excited to join the Regional team. I look forward to furthering the company’s progress and see Regional well positioned to weather the storm. We see opportunities to refinance some of our senior debt secured by U.S. Department of Housing and Urban Development (HUD) as well as other capital structure improvements.”

Management periodically monitors a number of facility performance metrics, including rent coverages both before and after management fees. In the fourth quarter of 2020, the Company’s portfolio rent coverage before management fees was 1.77x and rent coverage after management fees was 1.28x. Occupancy and skilled mix for the Company’s portfolio were 67.3% and 28.4% for the fourth quarter of 2020, respectively. These data exclude the impact of three managed facilities located in Ohio.

Rent Collections and Operator Changes

As of the year ended December 31, 2020, we collected 80% and 82% of contractual cash due for the fourth quarter of 2020 and twelve months ended December 31, 2020, respectively. As of the date of this press release, rent collections increased to 91% of contractual cash due for the year 2020. All expected contractual rent has been collected through March 2021.

As announced in December, we terminated a lease with the operator of two facilities located in Georgia. One facility was transitioned to Empire Care Centers, a new operator to Regional and the second building is being managed by Vero Health Care, a current leasee of the company. Preliminary operating results from January and February for these facilities are encouraging.

Summary of Financial Results for the Three and 12 Months Ended December 31, 2020

Total rental revenues in the fourth quarter of 2020 decreased 20.2% to $3.4 million, from $4.3 million in the fourth quarter of 2019. Total rental revenues for the 12 months ended December 31, 2020 decreased by 14.3% to $16.3 million, from $19.0 million for the twelve months ended December 31, 2019. The decrease is primarily a result of the agreement to terminate the subleases for two skilled nursing facilities in the fourth quarter of 2020 (the “Wellington Transition”) partially offset by four facilities sold during the third quarter of 2019 (the “Asset Sale”) as well as the disposition of two facilities we subleased “Omega Disposition” in the first quarter of 2019.

General and administrative costs increased 62.1%, to $1.0 million for the fourth quarter of 2020, compared with $641,000 for the same period in 2019. The increase for the fourth quarter includes approximately $100,000 of timing differences from recognition of Auditing and Accounting expenses (expensed as incurred) and approximately $300,000 in legal and consulting fees related to the Wellington Transition compared to the same period in 2019. General and administrative costs for the 12 months ended December 31, 2020 increased by 5.7%, to $3.4 million, compared with $3.2 million for the same period in 2019, the increase consists of $200,000 in consulting and legal fees and other insurance. Additionally for the 12 months ended December 31, 2020, and 2019, general and administrative costs include $49,000 and $92,000, respectively of stock-based compensation expense.

Provision (recovery) for doubtful accounts increased to $272,000 for the fourth quarter of 2020, compared with income of $67,000 for the same period in 2019. Provision (recovery) for doubtful accounts increased by approximately $1.2 million, to $925,000, for the twelve months ended December 31, 2020, compared with income of $281,000 for the year ended December 31, 2019. The current quarter and year expense is related to approximately $1.4 million provision of outstanding rent arrears and other straight-line adjustments arising from one operator (Wellington) offset by approximately $0.5 million of rent collection from prior year payment plans.

Interest expense decreased by $44,000, or 6.0%, to $686,000 for the fourth quarter of 2020 compared with $730,000 for the same period in 2019. Interest expense for the 12 months ended December 31, 2020, decreased by approximately $2.5 million or 47.3%, to $2.8 million compared to $5.3 million for the same period in 2019. The current quarter and year decrease is mainly due to the payoff of the Pinecone and Congressional Bank loans during the prior year from the proceeds of the Asset Sale.

Loss from discontinued operations, net of tax, for the fourth quarter of 2020, was $51,000 compared to income from discontinued operations, net of tax, of $215,000 for the prior year period. For the 12 months ended December 31, 2020, loss from discontinued operations, net of tax, was $84,000 compared to income from discontinued operations of $626,000 for the prior year period. The current year expense is primarily an adjustment to legacy accounts receivable. The prior period income is due to a $200,000 credit from one of the Company’s former attorneys, and $400,000 credit from legacy professional and general claims.

Net loss attributable to Regional Health Properties, Inc.’s common stockholders in the fourth quarter of 2020 was $3.3 million compared with a net loss of $1.5 million for the fourth quarter of 2019. For the 12 months ended December 31, 2020, the net loss attributable to Regional Health Properties, Inc.’s common stockholders was $9.7 million, or $5.74 per basic and diluted share, compared with a net loss of $3.5 million, inclusive of a $6.5 million pre-tax gain on the Asset Sale and $600,000 pre-tax gain from the Omega Disposition recognized during the first nine months of the year ended December 31, 2019, or $2.07 per basic and diluted share, in the prior year period.

Cash at December 31, 2020, totaled $4.2 million compared with $4.4 million at December 31, 2019. Restricted cash at December 31, 2020, totaled $3.3 million compared to $3.7 million at December 31, 2019. Total debt outstanding at December 31, 2020 amounted to $54.4 million compared with $55.4 million at December 31, 2019 (net of $1.3 million and $1.4 million of deferred financing costs at December 31, 2020 and 2019, respectively).

About Regional Health Properties

Regional Health Properties, Inc. (NYSE American: RHE) (NYSE American: RHEpA) is the successor to AdCare Health Systems, Inc., and is a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions.

Regional currently owns, leases, manages for third parties and operates, 24 facilities (12 of which are owned by Regional, nine of which are leased by Regional and three of which are managed by Regional for third parties). Effective January 1, 2021, the Company commenced operation of one previously subleased facility as a portfolio stabilization measure.

For more information, visit www.regionalhealthproperties.com.

Important Cautions Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “expects,” “intends,” “believes,” “anticipates,” “plans,” “likely,” “will,” “seeks,” “estimates” and variations of such words and similar expressions are intended to identify such forward-looking statements. Statements in this press release regarding future events and developments and our future performance, as well as management’s expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements.

Forward-looking statements, by their nature, involve estimates, projections, goals, forecasts and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those projected or contemplated by our forward-looking statements due to various factors, including, among others: our dependence on the operating success of our operators; the significant amount of, and our ability to service, our indebtedness; covenants in our debt agreements that may restrict our ability to make investments, incur additional indebtedness and refinance indebtedness on favorable terms; the availability and cost of capital; our ability to raise capital through equity and debt financings or through the sale of assets; the effect of increasing healthcare regulation and enforcement on our operators and the dependence of our operators on reimbursement from governmental and other third-party payors; the relatively illiquid nature of real estate investments; the impact of litigation and rising insurance costs on the business of our operators; the impact on us of litigation relating to our prior operation of our healthcare properties; the effect of our operators declaring bankruptcy, becoming insolvent or failing to pay rent as due; the ability of any of our operators in bankruptcy to reject unexpired lease obligations and to impede our ability to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor’s obligations; our ability to find replacement operators and the impact of unforeseen costs in acquiring new properties; the impact of COVID-19 on our business and the business of our operators, including without limitation, the extent and duration of the COVID-19 pandemic, increased costs experienced by our operators in connection therewith, and the extent to which government support may be available to our operators to offset such costs and the conditions related thereto; and other factors discussed from time to time in our news releases, public statements and documents filed by us with the Securities and Exchange Commission from time to time, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These forward-looking statements and such risks, uncertainties and other factors speak only as of the date of this press release, and we expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein, to reflect any change in our expectations with regard thereto or any other change in events, conditions or circumstances on which any such statement is based, except to the extent otherwise required by applicable law.

REGIONAL HEALTH PROPERTIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Amounts in 000’s)

 

 

 

 

 

ASSETS

December 31,

2020

 

December 31,

2019

 

 

 

 

 

 

 

 

Property and equipment, net

$

52,533

 

$

54,672

 

Cash

 

4,186

 

 

4,383

 

Restricted cash

 

3,306

 

 

3,655

 

Accounts receivable, net of allowance of $1,381 and $615

 

2,100

 

 

963

 

Prepaid expenses and other

 

328

 

 

249

 

Notes receivable

 

444

 

 

840

 

Intangible assets – bed licenses

 

2,471

 

 

2,471

 

Intangible assets – lease rights, net

 

158

 

 

462

 

Right-of-use operating lease assets

 

33,740

 

 

37,287

 

Goodwill

 

1,585

 

 

1,585

 

Lease deposits and other deposits

 

514

 

 

517

 

Straight-line rent receivable

 

6,660

 

 

6,674

 

Total assets

$

108,025

 

$

113,758

 

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

Senior debt, net

$

47,275

 

$

48,415

 

Bonds, net

 

6,342

 

 

6,409

 

Other debt, net

 

822

 

 

539

 

Accounts payable

 

3,008

 

 

3,699

 

Accrued expenses

 

2,225

 

 

2,613

 

Operating lease obligation

 

35,884

 

 

39,262

 

Other liabilities

 

1,365

 

 

1,078

 

Total liabilities

 

96,921

 

 

102,015

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 1,688 shares issued and outstanding at December 31, 2020 and December 31, 2019

 

62,041

 

 

61,992

 

Preferred stock, no par value; 5,000 shares authorized; 2,812 shares issued and outstanding, redemption amount $70,288 at December 31, 2020 and December 31, 2019

 

62,423

 

 

62,423

 

Accumulated deficit

 

(113,360

)

 

(112,672

)

Total stockholders’ equity

 

11,104

 

 

11,743

 

Total liabilities and stockholders’ equity

$

108,025

 

$

113,758

 

REGIONAL HEALTH PROPERTIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in 000’s, except per share data)

 

 

Three Months Ended December 31,

 

 

Twelve Months Ended December 31,

 

 

2020

 

2019

 

 

2020

 

2019

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental revenues

$

3,427

 

$

4,297

 

 

$

16,325

 

$

19,043

 

Management fees

 

269

 

 

279

 

 

 

1,001

 

 

995

 

Other revenues

 

29

 

 

3

 

 

 

253

 

 

96

 

Total revenues

 

3,725

 

 

4,579

 

 

 

17,579

 

 

20,134

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Facility rent expense

 

1,639

 

 

1,639

 

 

 

6,558

 

 

6,645

 

Cost of management fees

 

189

 

 

194

 

 

 

675

 

 

661

 

Depreciation and amortization

 

655

 

 

777

 

 

 

2,894

 

 

3,438

 

General and administrative expenses

 

1,039

 

 

641

 

 

 

3,373

 

 

3,192

 

Provision (recovery) for doubtful accounts

 

272

 

 

(67

)

 

 

925

 

 

(281

)

Other operating expenses

 

230

 

 

196

 

 

 

860

 

 

1,017

 

Total expenses

 

4,024

 

 

3,380

 

 

 

15,285

 

 

14,672

 

Income from operations

 

(299

)

 

1,199

 

 

 

2,294

 

 

5,462

 

Other expense (income):

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

686

 

 

730

 

 

 

2,777

 

 

5,265

 

Loss on extinguishment of debt

 

 

 

(20

)

 

 

 

 

2,458

 

Gain on disposal of assets

 

 

 

 

 

 

 

 

(7,141

)

Other expense (income), net

 

(23

)

 

 

 

 

121

 

 

6

 

Total other expense (income), net

 

663

 

 

710

 

 

 

2,898

 

 

588

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss) income from continuing operations before income taxes

 

(962

)

 

489

 

 

 

(604

)

 

4,874

 

Income tax expense

 

 

 

(44

)

 

 

 

 

 

(Loss) income from continuing operations

 

(962

)

 

533

 

 

 

(604

)

 

4,874

 

(Loss) income from discontinued operations, net of tax

 

(51

)

 

215

 

 

 

(84

)

 

626

 

Net (Loss) income

 

(1,013

)

 

748

 

 

 

(688

)

 

5,500

 

Preferred stock dividends – undeclared

 

(2,249

)

 

(2,249

)

 

 

(8,997

)

 

(8,997

)

Net (loss) income attributable to Regional Health Properties, Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stockholders

$

(3,262

)

$

(1,501

)

 

$

(9,685

)

$

(3,497

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share of common stock attributable to Regional Health Properties, Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

$

(1.90

)

$

(1.02

)

 

$

(5.69

)

$

(2.44

)

Discontinued operations

$

(0.03

)

$

0.13

 

 

$

(0.05

)

$

0.37

 

 

$

(1.93

)

$

(0.89

)

 

$

(5.74

)

$

(2.07

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

1,688

 

 

1,688

 

 

 

1,688

 

 

1,688

 

REGIONAL HEALTH PROPERTIES, INC. AND SUBSIDIARIES

SUPPLEMENTAL OPERATING METRICS (1)

 

 

Twelve Months

Ended

 

Twelve Months

Ended

 

Twelve Months

Ended

 

Twelve Months

Ended

 

Twelve Months

Ended

Portfolio Operating Metrics (1)

December 31, 2019

 

March 31, 2020

 

June 30, 2020

 

September 30, 2020

 

December 31, 2020

Occupancy %

76.5%

 

76.3%

 

75.1%

 

73.0%

 

67.3%

Quality Mix (2)

27.9%

 

27.7%

 

28.0%

 

29.3%

 

28.4%

Rent Coverage Before Management Fees (3)

 

1.57

 

 

1.59

 

 

1.55

 

 

1.58

 

 

1.77

Rent Coverage After Management Fees (3)

 

1.18

 

 

1.21

 

 

1.20

 

 

1.24

 

 

1.28

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Excludes three managed facilities in Ohio.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2) Quality Mix refers to all payor types less Medicaid.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3) EBITDAR coverage and EBITDARM coverage include information provided by our tenants. The Company has not independently verified this information, but have no reason to believe such information to be inaccurate in any material respect.

 

Company Contacts

Benjamin A. Waites

Chief Financial Officer and Vice President

Regional Health Properties, Inc.

Tel (678) 368-4393

[email protected]

Investor Relations

Brett Maas

Managing Partner

Hayden IR

Tel (646) 536-7331

[email protected]

KEYWORDS: Georgia United States North America

INDUSTRY KEYWORDS: REIT General Health Health Commercial Building & Real Estate Construction & Property

MEDIA: